Immune checkpoints as therapeutic targets in autoimmunity

Immune checkpoints as therapeutic targets in autoimmunity

Antibodies that block the immune checkpoint receptors PD1 and CTLA4 have revolutionized the treatment of melanoma and several other cancers, but in the process, a new class of drug side effect has emerged-immune related adverse events. The observation that therapeutic blockade of these inhibitory re...

Bibliográfalaš dieđut
Váldodahkkit:	Paluch, C, Santos, A, Anzilotti, C, Cornall, R, Davis, S
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	Frontiers Media 2018

Geahča maid

Immune Checkpoints as Therapeutic Targets in Autoimmunity
Dahkki: Christopher Paluch, et al.
Almmustuhtton: (2018-10-01)

Immune Checkpoints, a Novel Class of Therapeutic Targets for Autoimmune Diseases
Dahkki: Yujia Zhai, et al.
Almmustuhtton: (2021-04-01)

Combination CD200R/PD-1 blockade in a humanised mouse model
Dahkki: Fellermeyer, M, et al.
Almmustuhtton: (2023)

Manipulating immune checkpoint signalling pathways with antibodies
Dahkki: Paluch, C
Almmustuhtton: (2019)

Dermatological Autoimmune Considerations of Immune Checkpoint Therapy
Dahkki: Lauren S. Fane, et al.
Almmustuhtton: (2022-09-01)

Immune checkpoint deficiencies and autoimmune lymphoproliferative syndromes
Dahkki: Laura Gámez-Díaz, et al.
Almmustuhtton: (2021-08-01)

IMMUNE CHECKPOINT INHIBITION AND AUTOIMMUNITY: RHEUMATOLOGICAL PROBLEMS
Dahkki: E. L. Nasonov
Almmustuhtton: (2018-03-01)

CHECKPOINT ATHERO: developing immune checkpoint-based therapeutics for atherosclerosis
Dahkki: Lutgens, E, et al.
Almmustuhtton: (2023)

Immune Checkpoints: Novel Therapeutic Targets to Attenuate Sepsis-Induced Immunosuppression
Dahkki: Margaret A. McBride, et al.
Almmustuhtton: (2021-02-01)

The Role of Immune Checkpoint Molecules on Macrophages in Cancer, Infection, and Autoimmune Pathologies
Dahkki: Victoria C. Brom, et al.
Almmustuhtton: (2022-03-01)

Identification of shared mechanisms and targets between immune checkpoint inhibitor-associated myocarditis and autoimmune myocarditis
Dahkki: Kai Yang, et al.
Almmustuhtton: (2024-12-01)

Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
Dahkki: Mark P. Chao, et al.
Almmustuhtton: (2020-01-01)

Novel Immune Checkpoints in Esophageal Cancer: From Biomarkers to Therapeutic Targets
Dahkki: Xueyin Zhou, et al.
Almmustuhtton: (2022-05-01)

Therapeutic Monoclonal Antibodies Targeting Immune Checkpoints for the Treatment of Solid Tumors
Dahkki: Nicholas Gravbrot, et al.
Almmustuhtton: (2019-10-01)

Themis2: setting the threshold for B-cell selection.
Dahkki: Deobagkar-Lele, M, et al.
Almmustuhtton: (2017)

Single-cell transcriptomic analysis of retinal immune regulation and blood-retinal barrier function during experimental autoimmune uveitis
Dahkki: Quinn, J, et al.
Almmustuhtton: (2024)

Cancer immunotherapy by targeting immune checkpoints: mechanism of T cell dysfunction in cancer immunity and new therapeutic targets
Dahkki: Hwei-Fang Tsai, et al.
Almmustuhtton: (2017-05-01)

Targeting immune checkpoints in anti-neutrophil cytoplasmic antibodies associated vasculitis: the potential therapeutic targets in the future
Dahkki: Menglu Pan, et al.
Almmustuhtton: (2023-04-01)

Mathematical modelling of autoimmune myocarditis and the effects of immune checkpoint inhibitors
Dahkki: van der Vegt, SA
Almmustuhtton: (2022)

Mathematical modelling of autoimmune myocarditis and the effects of immune checkpoint inhibitors
Dahkki: van der Vegt, S, et al.
Almmustuhtton: (2022)

Research progress of immune checkpoint inhibitor related autoimmune hypophysitis
Dahkki: LI Jia-yi, XING Bing
Almmustuhtton: (2020-03-01)

Antiviral Innate Immune Responses in Autoimmunity: Receptors, Pathways, and Therapeutic Targeting
Dahkki: Eirini Maria Stergioti, et al.
Almmustuhtton: (2022-11-01)

Editorial: Co-inhibitory immune checkpoint proteins as biomarkers and therapeutic targets in cancer
Dahkki: Caroline E. Nunes-Xavier
Almmustuhtton: (2024-09-01)

Immune Checkpoints in Pediatric Solid Tumors: Targetable Pathways for Advanced Therapeutic Purposes
Dahkki: Claudia Cocco, et al.
Almmustuhtton: (2021-04-01)

Therapeutic Targeting of DNA Damage Repair in the Era of Precision Oncology and Immune Checkpoint Inhibitors
Dahkki: Curtis A. Clark, et al.
Almmustuhtton: (2023-01-01)

Immune checkpoint inhibitors in cancer patients with autoimmune disease: Safety and efficacy
Dahkki: Jiayuan Le, et al.
Almmustuhtton: (2025-12-01)

Immune Checkpoint Inhibitor-Related Autoimmune Pancreatitis—Risk Factors and Outcomes
Dahkki: Shashank Nuguru, et al.
Almmustuhtton: (2024-01-01)

Increased Intrahepatic Expression of Immune Checkpoint Molecules in Autoimmune Liver Disease
Dahkki: Zuzana Macek Jilkova, et al.
Almmustuhtton: (2021-10-01)

Immune-checkpoint protein VISTA in allergic, autoimmune disease and transplant rejection
Dahkki: Meijun Zheng, et al.
Almmustuhtton: (2023-06-01)

Efficacy and Toxicity of Immune -Checkpoint Inhibitors in Patients With Preexisting Autoimmune Disorders
Dahkki: Michelle Coureau, et al.
Almmustuhtton: (2020-05-01)

Changes in the level of immune checkpoints in patients with various forms of autoimmune thyroiditis
Dahkki: V. V. Babinsky
Almmustuhtton: (2024-09-01)

Pathogenesis of Autoimmune Cytopenias in Inborn Errors of Immunity Revealing Novel Therapeutic Targets
Dahkki: Manuela Cortesi, et al.
Almmustuhtton: (2022-04-01)

Profiling targetable immune checkpoints in osteosarcoma
Dahkki: Troy A McEachron, et al.
Almmustuhtton: (2018-12-01)

Immune Checkpoint Inhibition and the Prevalence of Autoimmune Disorders Among Patients With Lung and Renal Cancer
Dahkki: Sherif M El-Refai, et al.
Almmustuhtton: (2017-05-01)

Galectin-9 in cancer therapy: from immune checkpoint ligand to promising therapeutic target
Dahkki: Minpu Zhang, et al.
Almmustuhtton: (2024-01-01)

Targeting the TIGIT-PVR immune checkpoint axis as novel therapeutic option in breast cancer
Dahkki: Hauke Stamm, et al.
Almmustuhtton: (2019-12-01)

Tolerance and autoimmunity in the eye: a role for CD8 T cells in organ-specific autoimmunity in the retina.
Dahkki: Forrester, J, et al.
Almmustuhtton: (2003)

New Therapeutic Targets in Autoimmune Cholangiopathies
Dahkki: Alessio Gerussi, et al.
Almmustuhtton: (2020-04-01)

Targeting immune checkpoints in hematological malignancies
Dahkki: Basit Salik, et al.
Almmustuhtton: (2020-08-01)

Copper and cuproptosis-related genes in hepatocellular carcinoma: therapeutic biomarkers targeting tumor immune microenvironment and immune checkpoints
Dahkki: Xiaoqiang Wang, et al.
Almmustuhtton: (2023-04-01)